S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
Log in

NYSE:EWEdwards Lifesciences Price Target & Analyst Ratings

$76.60
-1.42 (-1.82 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$76.05
Now: $76.60
$77.94
50-Day Range
$67.13
MA: $72.01
$79.33
52-Week Range
$51.51
Now: $76.60
$82.55
Volume2.00 million shs
Average Volume4.14 million shs
Market Capitalization$47.63 billion
P/E Ratio65.85
Dividend YieldN/A
Beta0.88

Analyst Ratings

Edwards Lifesciences (NYSE:EW) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
20 Wall Street analysts have issued ratings and price targets for Edwards Lifesciences in the last 12 months. Their average twelve-month price target is $84.81, suggesting that the stock has a possible upside of 10.71%. The high price target for EW is $95.00 and the low price target for EW is $51.67. There are currently 1 sell rating, 5 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.652.612.612.52
Ratings Breakdown: 1 Sell Rating(s)
5 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $84.81$82.77$82.76$83.42
Price Target Upside: 10.71% upside23.30% upside12.91% upside63.91% downside

Edwards Lifesciences (NYSE:EW) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Edwards Lifesciences (NYSE:EW) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/24/2020Stifel NicolausBoost Price TargetBuy$85.00 ➝ $90.00Low
7/24/2020Canaccord GenuityBoost Price TargetBuy$86.00 ➝ $89.00Medium
7/24/2020Jefferies Financial GroupBoost Price TargetBuy$87.00 ➝ $95.00Low
7/24/2020Credit Suisse GroupBoost Price TargetOutperform$88.00 ➝ $92.00High
7/24/2020Morgan StanleyBoost Price TargetOverweight$83.00 ➝ $88.00High
7/24/2020SVB LeerinkBoost Price TargetOutperform$90.00 ➝ $95.00High
7/24/2020Raymond JamesBoost Price TargetOutperform$83.00 ➝ $88.00High
7/24/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$88.00 ➝ $91.00High
7/13/2020OppenheimerInitiated CoverageBuy$93.00High
4/28/2020Wells Fargo & CoDowngradeOverweight ➝ Equal Weight$83.33 ➝ $76.67High
4/27/2020BarclaysReiterated RatingUnderweight$55.00 ➝ $51.67High
4/24/2020CfraBoost Price TargetBuy$67.00 ➝ $77.00Low
4/24/2020CitigroupBoost Price TargetBuy$80.00 ➝ $85.00High
4/23/2020BTIG ResearchReiterated RatingHoldHigh
4/22/2020Deutsche BankLower Price TargetHold$81.67 ➝ $75.00Low
4/20/2020CowenLower Price TargetTop Pick ➝ Outperform$91.67 ➝ $83.33Medium
2/12/2020Goldman Sachs GroupInitiated CoverageNeutral$84.33Low
1/31/2020UBS GroupBoost Price TargetNeutral$85.00 ➝ $86.67High
12/9/2019Piper Jaffray CompaniesBoost Price TargetOverweight$85.00 ➝ $87.33High
10/22/2019Royal Bank of CanadaBoost Price TargetBuy ➝ Outperform$72.33 ➝ $83.33Medium
7/24/2019BMO Capital MarketsBoost Price TargetOutperform$68.00 ➝ $74.67Low
7/24/2019JPMorgan Chase & Co.Boost Price TargetNeutral$63.33 ➝ $75.00Low
7/24/2019Bank of AmericaReiterated RatingBuy ➝ Buy$71.67 ➝ $75.00Low
10/11/2018Northland SecuritiesReiterated RatingHold$40.00Medium
10/2/2018GuggenheimDowngradeBuy ➝ NeutralHigh
9/28/2018SunTrust BanksBoost Price TargetBuy$66.67Medium
6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$55.00High
2/2/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$45.00 ➝ $46.67High
1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$46.67High
8/28/2017William BlairReiterated RatingOutperform ➝ OutperformLow
(Data available from 8/4/2018 forward)
This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.